Work

Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor

Year: 1995

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Arteriosclerosis Thrombosis and Vascular Biology

DOI: 10.1161/01.atv.15.5.678

Authors: James W. Nawrocki, Stuart R. Weiss, Michael H. Davidson, Dennis L. Sprecher, Sherwyn L. Schwartz, Paul-J. Lupien, Peter H. Jones, Harry E. Haber, Donald M. Black

Institutions: Baylor College of Medicine, University of Michigan, Diabetes & Glandular Disease Clinic, University of Cincinnati

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2106536809

FWCI: 32.83

Cites: 17

Cited by: 487

Related to: 10